Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2012;7(10):e46042.
doi: 10.1371/journal.pone.0046042. Epub 2012 Oct 3.

Statistical analysis of individual participant data meta-analyses: a comparison of methods and recommendations for practice

Affiliations
Comparative Study

Statistical analysis of individual participant data meta-analyses: a comparison of methods and recommendations for practice

Gavin B Stewart et al. PLoS One. 2012.

Abstract

Background: Individual participant data (IPD) meta-analyses that obtain "raw" data from studies rather than summary data typically adopt a "two-stage" approach to analysis whereby IPD within trials generate summary measures, which are combined using standard meta-analytical methods. Recently, a range of "one-stage" approaches which combine all individual participant data in a single meta-analysis have been suggested as providing a more powerful and flexible approach. However, they are more complex to implement and require statistical support. This study uses a dataset to compare "two-stage" and "one-stage" models of varying complexity, to ascertain whether results obtained from the approaches differ in a clinically meaningful way.

Methods and findings: We included data from 24 randomised controlled trials, evaluating antiplatelet agents, for the prevention of pre-eclampsia in pregnancy. We performed two-stage and one-stage IPD meta-analyses to estimate overall treatment effect and to explore potential treatment interactions whereby particular types of women and their babies might benefit differentially from receiving antiplatelets. Two-stage and one-stage approaches gave similar results, showing a benefit of using anti-platelets (Relative risk 0.90, 95% CI 0.84 to 0.97). Neither approach suggested that any particular type of women benefited more or less from antiplatelets. There were no material differences in results between different types of one-stage model.

Conclusions: For these data, two-stage and one-stage approaches to analysis produce similar results. Although one-stage models offer a flexible environment for exploring model structure and are useful where across study patterns relating to types of participant, intervention and outcome mask similar relationships within trials, the additional insights provided by their usage may not outweigh the costs of statistical support for routine application in syntheses of randomised controlled trials. Researchers considering undertaking an IPD meta-analysis should not necessarily be deterred by a perceived need for sophisticated statistical methods when combining information from large randomised trials.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Forest plot of relative risks of developing pre-eclampsia (fixed-effect inverse variance model based on two-stage analysis replicating the analysis of [29]).
Q(df = 23) = 31.19, p = 0.12, I2 = 26.3.

References

    1. Stewart LA, Parmar MKB (1993) Meta-analysis of the literature or of individual participant data: is there a difference? Lancet 341: 418–22. - PubMed
    1. Stewart LA, Clarke MJ (1995) Practical methodology of meta-analyses (overviews) using updated individual participant data. Statistics in Medicine 14: 2057–79. - PubMed
    1. Stewart LA, Tierney JF, Burdett S (2005) Do systematic reviews based on individual participant data offer a means of circumventing biases associated with trial publications? In Rothstein H, Sutton A, Borenstein M. Publication Bias in Meta-Analysis: Prevention, Assessment and Adjustments. John Wiley & Sons, 261–86.
    1. Clarke MJ, Stewart LA (2001) Obtaining individual participant data from randomised controlled trials. In: Egger M, Davey-Smith G, Altman DG, Eds. Systematic Reviews in Healthcare: Meta-analysis in context. London: BMJ Publishing Group, pp 109–21.
    1. Riley RD, Lambert PC, Abo-Zaid G (2010) Meta-analysis of individual participant data: rationale, conduct and reporting. British Medical Journal 340: c221. - PubMed

Publication types

Substances